Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$27.26
1.023.89%
Last update: Oct 9, 6:24 PM
$26.94
0.702.67%
Zenas BioPharma Inc (ZBIO) Stock Price, Quote, News & History
ZBIONASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Zenas BioPharma (NASDAQ:ZBIO) through any online brokerage.
Other companies in Zenas BioPharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Zenas BioPharma has a consensus price target of $40.78.
The stock price for Zenas BioPharma (NASDAQ: ZBIO) is $26.94 last updated October 9, 2026 at 6:24 PM EDT.
There are no upcoming dividends for Zenas BioPharma.
Zenas BioPharma does not have any upcoming earnings scheduled.
There is no upcoming split for Zenas BioPharma.
Zenas BioPharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
